期刊文献+

细胞质胸苷激酶在维吾尔族妇女宫颈癌的表达及临床意义 被引量:2

Expression of TK1 in cervical carcinoma in Uighur women and its clinical significance.
下载PDF
导出
摘要 目的:探讨细胞质胸苷激酶(TK1)在宫颈鳞癌的表达及其临床意义。方法:制备40例维吾尔族妇女子宫颈癌及正常宫颈组织中总RNA,用RT-PCR方法分析TK1基因mRNA的表达水平,用免疫组化(SP)法检测其相应蛋白表达。结果:(1)维吾尔族妇女宫颈癌组织中TK1 mRNA及蛋白阳性检出率分别为67.5%及60.5%,对照组宫颈组织中检出率为26.7%及8.3%。宫颈癌组织中TK1 mRNA及蛋白阳性表达明显高于对照组的宫颈组织(P<0.05);(2)在宫颈癌组织中TK1 mRNA及蛋白表达:不同临床分期及分化程度之间无显著差异(P>0.05),但是,有淋巴结转移患者组织中阳性表达明显高于无淋巴结转移者,肿瘤直径≥4cm患者阳性表达明显高于肿瘤直径<4cm的患者(P<0.05)。结论:TK1在维吾尔族妇女宫颈鳞癌中高表达,对宫颈癌的诊断有重要的参考价值,TK1高表达可能与宫颈癌的进展及预后有关。 Objective:To explore the expression of TK1 mRNA and protein and its significance in cervical carcinoma in Uighur women.Methods:TK1 mRNA expression were evaluated by RT-PCR and TK1 protein expression were detected by immunohistochemistry method(SP) in 40 cases of cervical carcinoma in Uighur women.Results:(1)The positive expression rates of TK1mRNA and TK1 protein in cervical carcinoma were 67.5% and 60.5%,which were significantly higher than 26.7% and 8.3% in control group.(2)The positive expression rates of TK1mRNA and TK1 protein were obviously higher in lymph node metastatic group and the group with tumor diameter more than 4cm than non-metastatic group and the group of less than 4cm,respectively(P0.05),while no significant differences between different clinical stages and pathological grades(P0.05).Conclusion:TK1 has a substantial diagnostic value for cervical carcinoma in uighur women,which may be related to its progress and prognosis.
出处 《现代妇产科进展》 CSCD 北大核心 2010年第8期601-604,共4页 Progress in Obstetrics and Gynecology
基金 新疆维吾尔自治区重点实验室基金项目(No:XJDX0208-2006-03)
关键词 维吾尔族妇女 宫颈肿瘤 细胞质胸苷激酶 逆转录聚合酶链反应 免疫组织化学 Uighur women Cervix neoplasms Thymidine kinase Reverse transcription polymerase chain reaction Immunohistochemistry
  • 相关文献

参考文献13

  • 1Brot P, Romain S, Daver A, et al. Thymidine kinase as a proliferative marker: clinical relevance in 1692 primary breast cancer patients [ J ]. J Clin Oncol, 2001,19 : 2778- 2787.
  • 2陆敏 周宜男 徐瑛.和田地区维吾尔族5088已婚妇女子宫颈癌普查资料分析.新疆医药,1979,7:17-17.
  • 3姜淑清,土送爱,周俊兰,买热木尼沙汗,碧佳娜提,茹仙姑丽,沙来买提,徐雪,海日尼沙汗,艾木热汗.新疆策勒县妇女病现状调查与分析[J].中国妇幼保健,2006,21(4):524-526. 被引量:50
  • 4Ke PY, Chang ZF. Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/ cyclosome-CDHl-mediated pathway [ J ]. Mol Cell Biol,2004,24 : 514-526.
  • 5Wu C J, Yang RJ,Zhou J,et al. Production and characterisation of a novel chicken IgY antibody raised against Cterminal peptide from human thymidine kinase 1 [ J ]. Immunol Methods,2003,277 : 157-169.
  • 6Zhang J,Jia Q,Zou S, et al. Thymidine kinase l:a proliferation marker for determining prognosis and monitoring the surgical .out come of primary bladder carcinoma patients [ J ]. Oncol Rep, 2006,15455-15461.
  • 7Fujiwaki R, Hata K, Moriyama M, et al. Clinical value of thymidine kinase in patients with cervical carcinoma [ J ]. Oncology, 2001,61:47-54.
  • 8张毅敏,单绿虎,徐笑红.细胞质胸苷激酶1在106例肿瘤病人的表达[J].中国肿瘤,2008,17(3):247-248. 被引量:29
  • 9吴怡春,徐笑红,张毅敏,褚美芬,何凡.血清TK1水平变化在恶性肿瘤诊疗转归过程的监测作用[J].中国卫生检验杂志,2008,18(6):1122-1123. 被引量:19
  • 10Pan ZL,Ji XY,Shi YM. et al. Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin's lymphoma patients [ J ]. Cancer Res Clin Oncol,2010 ,7 :54-54.

二级参考文献24

  • 1王金桃,高尔生,程玉英,闫建文,丁玲.宫颈癌危险因素病例对照研究[J].中国公共卫生,2004,20(2):161-162. 被引量:37
  • 2朱向东.2000年人口普查分县资料[M].北京:中国统计出版社,2003.98.
  • 3连利娟.林巧稚妇科肿瘤学·第3版[M].北京:人民卫生出版社,2001.210.
  • 4Barlhel H, Perumal M, Latigo J, et al. The uptake of 3'- deoxy-3'-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels [J]. Eur J Nucl Med Mol Imaging, 2005, 32(3):257-263.
  • 5Buck AK, Bommer M, Stilgenbauer S, et al. Molecular imaging of proliferation in malignant lymphoma[J]. Cancer Res, 2006, 66(22):11055-11061.
  • 6Arner ES. Eriksson S, Mannalian deoxyribonucleoside kinases[J]. Phamac Ther, 1995, 67(2):155-186
  • 7Hallek M, Touiton Y, Levi F, et al. Serum thymidine kinase levels are elevated and exhibit diurnal variations in patients with advanced ovarian cancer[J]. Clin Chim Acta, 1997, 267(2):155-166.
  • 8Broet P, Romain S, Daver A,et al. Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients [J]. J Clin Oncol, 2001, 19(11): 2778-2787.
  • 9Mizutani Y, Nakanishi H, Li YN, et al. Prognostic significance of thymidine kinase activity in renal cell carcinoma [J]. Proc Amer Assoc Cancer Res, 2004, 45(3):267.
  • 10Brockenbrough S, Rasey J, Grierson J, et al. Assay of cytosolic thymidine kinase Ⅰ (TK1) activity in human lung lesions[J]. J Nucl Med, 2007, 48(Suppl 2):81P.

共引文献93

同被引文献31

  • 1ZHANG F,LI H,PENDLETON AR,et al. Thymidine kinase 1 im- munoassay : a potential marker for breast cancer[ J ]. Cancer Detec- tion Prevention ,2001,25 ( 1 ) :8 - 15.
  • 2Ke PY,Hu CM,Chang YC,et al.Hiding human thymidine kinase 1 from APC/C-mediated destruction by thymidine binding[J].FASEB J,2007,21(4):1276-1284.
  • 3Pérez-Pérez MJ,Priego EM,Hernández AI,et al.Structure,physiological role,and specific inhibitors of human thymidine kinase 2 (TK2):present and future[J],Med Res Rev,2008,28(5):797-820.
  • 4Zhang J,Jia Q,Zou S,et al.Thymidine kinase 1:a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients[J].Oncol Rep,2006,15(2):455-461.
  • 5Chabes A,Thelander L.DNA building blocks at the foundation of better survival[J].Cell Cycle,2003,2 (3):171-173.
  • 6Munch-Petersen B.Reversible tetramerization of human TK1 to the high catalytic efficient form is induced by pyrophosphate,in addition to tripolyphosphates,or high enzyme concentration[J].FEBS J,2009,276(2):571-580.
  • 7Welin M,Kosinska U,Mikkelsen NE,et al.Structures of thymidine kinase 1 of human and mycoplasmic origin[J].Proc Natl Acad Sci U S A,2004,101(52):17970-17975.
  • 8Mao Y,Wu J,Wang N,et al.A comparative study:immunohistochemical detection of cytosolic thymidine kinase and proliferating cell nuclear antigen in breast cancer[J].Cancer Invest,2002,20 (7-8):922-931.
  • 9He Q,Zou L,Zhang PA,et al.The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody[J].Int J Biol Markers,2000,15 (2):139-146.
  • 10Mao Y,Wu J,Skog S,et al.Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling[J].Oncol Rep,2005,13(5):837-846.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部